Botfet / Company detail

RGEN

rejected

Repligen Corporation

biotech

Moat scoreNot available: not scored quality failout of 100

Rejectionquality_fail

The numbers

Financial metrics

Quality gate and thesis context

Roic1.7%

Gross Margin47.1%

Revenue Cagr2.4%

Fcf Conversion192.0%

Fcf Yield0.8%

Interest Coverage7.9x

Market Cap B$11.5B

Pe239.1

Quality PassFail

Founder LedNo

Thesis AlignedYes

Moat QuantNot available: not scored quality fail

Why it may endure

Quant: · Curator:

Market Share StabilityNot available: not scored quality fail

Network EffectsNot available: not scored quality fail

Pricing PowerNot available: not scored quality fail

Regulatory MoatNot available: not scored quality fail

Switching CostsNot available: not scored quality fail

ConvictionNot available: not scored quality fail

LeadershipNot available: not scored quality fail

VisionNot available: not scored quality fail